Company / Working Capital
OptimizeRx Corp Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$43.5M
FY2025
5-year range
$22.8M / $90.2M
FY2021-FY2025
Trend
+23.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital returned to growth in FY2025 after 2 years of decline, reaching $43M.
Based on SEC 10-K filings.
$43M in FY2025 with a 5-year CAGR of +13.7%.
Improved from $36M to $43M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -21.6%
- 5-Year CAGR
- +13.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +13.7%, indicating consistent growth.
- In FY2025, working capital increased 23.0% year-over-year.
- Peak working capital was recorded in FY2022.
- Lowest working capital in the period was in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $43.5M | +23.0% |
| FY2024 | $35.3M | -3.1% |
| FY2023 | $36.4M | -59.6% |
| FY2022 | $90.2M | +295.0% |
| FY2021 | $22.8M | +0.0% |
| FY2020 | $22.8M | +8.5% |
| FY2019 | $21.0M | +79.3% |
| FY2018 | $11.7M | +122.8% |
| FY2017 | $5.3M | -19.1% |
| FY2016 | $6.5M | -16.1% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026